Latest

    All News
    Editorial illustration for Biotech Startup Fundraising FDA Pathway - startups insights
    Startups

    Biotech Startup Fundraising FDA Pathway

    Biotech startups face a financing paradox: burning $2-5M monthly in clinical development while years from revenue. Discover how FDA pathway selection determines fundraising strategy, capital structure, and valuation inflection points from seed to Series B.

    Sarah Mitchell··12 min read
    Editorial illustration for Early Exercise of Stock Options: Tax Advantages Founders Miss - capital-raising insights
    Capital Raising

    Early Exercise of Stock Options: Tax Advantages Founders Miss

    Early exercise of stock options allows founders to buy shares before vesting, potentially reducing tax liability by millions. When executed at formation when strike price equals fair market value, it eliminates Alternative Minimum Tax entirely.

    Rachel Vasquez··13 min read
    Editorial illustration for Shadow Board Meetings for Early Stage Startups - capital-raising insights
    Capital Raising

    Shadow Board Meetings for Early Stage Startups

    Shadow boards—advisory groups of younger employees providing strategic insights to leadership—are shifting from Fortune 500 novelty to early-stage necessity. For startups raising capital, they offer low-cost governance that signals maturity to investors.

    Rachel Vasquez··8 min read
    Editorial illustration for Investor Commitment Letter vs Term Sheet (2025) - market-analysis insights
    Market Analysis

    Investor Commitment Letter vs Term Sheet (2025)

    A term sheet is a non-binding financing outline, while a commitment letter represents formal approval to close. Discover why this distinction matters for founders navigating capital raises.

    Marcus Cole··12 min read
    Editorial illustration for AllSides RegCF Offering: Media Bias Platform Seeks Capital - Startups insights
    Startups

    AllSides RegCF Offering: Media Bias Platform Seeks Capital

    AllSides, a media bias rating platform founded in 2012, launched a Regulation Crowdfunding campaign on Wefunder targeting $13,000 in capital to expand its public benefit corporation operations.

    Sarah Mitchell··11 min read
    Editorial illustration for BackerKit RegCF Crowdfunding: $1M Raise on Wefunder - Startups insights
    Startups

    BackerKit RegCF Crowdfunding: $1M Raise on Wefunder

    BackerKit launched a $1 million Regulation Crowdfunding offering on Wefunder to fund Castle Zagyg Volumes 4-5, completing Gary Gygax's unpublished mega-dungeon adventure series for Castles & Crusades tabletop RPG.

    Sarah Mitchell··10 min read

    Invest Smarter With Angel Investors Network

    The Wealthy Renegade

    Alternative Investment Intelligence

    Our flagship investment newsletter delivering weekly insights on angel investing opportunities, market analysis, and wealth-building strategies for sophisticated investors.

    • Weekly market analysis & investment opportunities
    • Exclusive deal flow and startup spotlights
    • Tax strategies for alternative investors (QSBS, 1031, etc.)
    • Portfolio construction frameworks
    • Direct access to our research team
    Learn More

    Join 50,000+ investors

    Mastermind Investment Club

    Exclusive Access • Curated Deal Flow

    Our invite-only investment club for serious investors. Get direct access to pre-vetted investment opportunities, participate in syndicate deals, and connect with fellow HNW investors and fund managers.

    • Curated, pre-vetted investment opportunities
    • Syndicate deal participation
    • Monthly mastermind calls with industry leaders
    • Private investor community & networking
    • Priority access to AIN events and deal flow
    Apply to Join

    Limited membership • Application required

    Popular Topics

    View All

    Get the latest investment intelligence delivered to your inbox

    Weekly insights on deal flow, market trends, and investment strategies from our editorial team. Free.

    Join 50,000+ readers • No spam ever • Unsubscribe anytime